Hebe dich für diese Rolle ab — erstelle in etwa einer Minute einen maßgeschneiderten Lebenslauf und ein Anschreiben.
Optimapharm in Germany is seeking a CRA (CRA I–IV track) to monitor sites in early to later phase clinical studies. You will join a global CRO, contribute to patient-focused trials, and progress through a defined CRA career path. A sign-on bonus is offered.
The position offers growth within a proactive, matrix‑managed team, flexible hours, and a chance to work on diverse international projects with experienced CRAs.
Location: Preferably in the northern part of Germany
Optimapharm is a mid-sized, global Contract Research Organisation (CRO) turning science into hope through agile, patient-focused clinical development. We specialise in Phase I–IV clinical studies, delivering Full-Service and Functional Service Provision (FSP) solutions that help sponsors move faster and execute with confidence.
With operations in 40+ countries and 2x the patient reach of the average mid-sized CRO, we enable accelerated regulatory pathways, faster study start-up, and access to diverse patient populations worldwide. At Optimapharm, you’ll contribute to meaningful clinical research while growing your career in a dynamic, people‑focused, global environment.
We’re looking for a new CRA – whether you’re building your expertise as a CRA II or ready to step into a higher CRA role, this is your chance to shape the future of clinical research – delivering excellence for our sponsors and meaningful impact for patients and families worldwide. This role sits within a defined CRA career path: CRA I → CRA II → CRA III → Senior CRA.
Incentive: Sign-on bonus included
By joining our fast-growing and prosperous team, you will have an excellent opportunity for further personal growth and career development.
Compensation is competitive and final offers will reflect each candidate’s experience, skills, and qualifications.